Why the study?
Although left atrial appendage closure is an alternative to long-term anticoagulation, there remains a residual risk of cerebrovascular events during follow-up.
Answers are grounded in this paper and cite their sources.
Patients undergoing LAAc remain at residual risk for ischemic and hemorrhagic strokes up to 3 years post-procedure, particularly those with hypertension or severely reduced LVEF (<20%).
Background Although left atrial appendage closure (LAAc) has evolved as an alternative to long-term anticoagulation for prevention of thromboembolism, but there is still residual risk of cerebrovascular events during the follow-up period after LAAc. Purpose In our study, we sought to assess the incidence and risk of residual cerebrovascular events after LAAc from a large, real-world based dataset. Methods We identified a total of 12,903 patients who underwent LAAc during the time-period of 01/2025 and 10/2022. For the purpose of our analysis, we had excluded patients with prior history of cerebrovascular events. We then assessed the incidence of cerebrovascular events (stratified by etiology: ischemic vs. hemorrhagic) at 30-day, 1-year and 3-year follow-up time period after the LAAc procedure. To assess the risk-factors of cerebrovascular events, we then conducted logistic regression using Cox-proportional hazard model for ischemic and hemorrhagic etiologies separately. Results Overall, the incidence of ischemic stroke and hemorrhagic stroke were 0.4% and 0.1% during the initial 30-days after the LAAc procedure. At 1 year follow-up the rates of ischemic and hemorrhagic strokes were 2.5% and 0.6%, with the 3-year rates being 6.1% and 1.2% respectively (Figure). On multivariable analysis, type 2 diabetes mellitus (adjusted HR: 1.08, 95% CI of 1.01-1.2, p = 0.04), hypertension (adjusted HR of 1.5, 95% CI of 1.28-1.63, p < 0.0001) and impaired left ventricular ejection fraction (EF of < 20%, adjusted HR of 1.5, 95% CI of 1.14-1.93, p = 0.003) were independently associated with the increased risk of ischemic stroke after LAAc. In our analyses for hemorrhagic stroke after LAAc, we observed impaired LVEF of < 20% (adjusted HR of 2.02, 95% CI of 1.30- 3.14, p = 0.002) and HTN (adjusted HR of 1.6, 95% CI of 1.28-1.97, p < 0.0001) to be the independent risk factors. Conclusions In our study based on a large, real-world dataset, we observed residual risk of both ischemic and hemorrhagic cerebrovascular events both at short-term and long-term follow-up time intervals after LAAc. Pre-procedural risk factors such as a significantly impaired LVEF of < 20% and HTN were important risk factors for both these events. Our findings highlight the need for considering these 2 risk factors to guide management of risk-factors and anticoagulation regimen after LAAc.
No takes yet. Share an insight, caveat, or question.
Maan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: